User contributions for Mohamed Moubarak
Results for Mohamed Moubarak talk block log uploads logs
A user with 3,170 edits. Account created on 3 September 2013.
10 January 2014
- 06:3606:36, 10 January 2014 diff hist +4 Elvitegravir cobicistat emtricitabine tenofovir →Category current
- 06:3606:36, 10 January 2014 diff hist +606 Elvitegravir cobicistat emtricitabine tenofovir →Overview
- 06:3406:34, 10 January 2014 diff hist +24 Elvitegravir cobicistat emtricitabine tenofovir →Mechanism of Action
- 06:3306:33, 10 January 2014 diff hist 0 Elvitegravir cobicistat emtricitabine tenofovir →Mechanism of Action
- 06:3306:33, 10 January 2014 diff hist +2,202 Elvitegravir cobicistat emtricitabine tenofovir →Mechanism of Action
- 06:3106:31, 10 January 2014 diff hist +228 N Elvitegravir cobicistat emtricitabine tenofovir labels and packages Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Labels and Packages== 750px ==References== {{Reflist}} {{F..." current
- 06:3006:30, 10 January 2014 diff hist 0 N File:Stribild label.jpg No edit summary current
- 06:2906:29, 10 January 2014 diff hist +1,068 N Elvitegravir cobicistat emtricitabine tenofovir how supplied Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==How Supplied== STRIBILD tablets are green, capsule-shaped, film-coated, debossed with "..." current
- 06:2706:27, 10 January 2014 diff hist +2,540 N Elvitegravir cobicistat emtricitabine tenofovir dosage and administration Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Dosage and Administration== ===Dosage Information=== The recommended dosage of STRIBIL..." current
- 06:2606:26, 10 January 2014 diff hist +3,033 N Elvitegravir cobicistat emtricitabine tenofovir overdosage Created page with "_NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Overdosage== No data are available on overdose of STRIBILD in patients. If overdose occu..." current
- 06:2506:25, 10 January 2014 diff hist +3,772 N Elvitegravir cobicistat emtricitabine tenofovir drug interactions Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Drug Interactions== ===Other Antiretroviral Medications=== STRIBILD is a complete regi..." current
- 06:2206:22, 10 January 2014 diff hist +1,025 N Elvitegravir cobicistat emtricitabine tenofovir adverse reactions Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==ADVERSE Reactions== The following adverse drug reactions are discussed in other section..." current
- 06:1706:17, 10 January 2014 diff hist +8,980 Elvitegravir cobicistat emtricitabine tenofovir warnings and precautions No edit summary current
- 06:1506:15, 10 January 2014 diff hist +929 N Elvitegravir cobicistat emtricitabine tenofovir contraindications Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Contraindications== Coadministration of STRIBILD is contraindicated with drugs that ar..."
- 06:1406:14, 10 January 2014 diff hist 0 N File:Stribild table 1.jpg No edit summary current
- 06:1306:13, 10 January 2014 diff hist +681 N Elvitegravir cobicistat emtricitabine tenofovir indications and usage Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Indications and Usage== STRIBILD® is indicated as a complete regimen for the treatment..."
- 06:1206:12, 10 January 2014 diff hist +19,740 N Elvitegravir cobicistat emtricitabine tenofovir (patient information) Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Patient Information== See FDA-Approved Patient Labeling (Patient Information) A statem..." current
- 06:1006:10, 10 January 2014 diff hist +1 Elvitegravir cobicistat emtricitabine tenofovir No edit summary
- 06:0906:09, 10 January 2014 diff hist +128 Elvitegravir cobicistat emtricitabine tenofovir No edit summary
- 06:0606:06, 10 January 2014 diff hist +8 Elvitegravir cobicistat emtricitabine tenofovir microbiology No edit summary current
- 06:0406:04, 10 January 2014 diff hist +9,573 N Elvitegravir cobicistat emtricitabine tenofovir microbiology Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Microbiology== *'''Mechanism of Action''' Elvitegravir: Elvitegravir inhibits the stran..."
- 05:5905:59, 10 January 2014 diff hist +9,512 N Elvitegravir cobicistat emtricitabine tenofovir clinical pharmacology Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Clinical Pharmacology== ===Pharmacodynamics=== Effects on Electrocardiogram Thorough QT..." current
- 05:4605:46, 10 January 2014 diff hist 0 N File:Stribild table7.jpg No edit summary current
- 05:4105:41, 10 January 2014 diff hist +3,876 N Elvitegravir cobicistat emtricitabine tenofovir description Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Description== STRIBILD is a fixed-dose combination tablet containing elvitegravir, cobi..." current
- 05:4005:40, 10 January 2014 diff hist 0 N File:Stribild description 4.jpg No edit summary current
- 05:3905:39, 10 January 2014 diff hist 0 N File:Stribild description 3.jpg No edit summary current
- 05:3805:38, 10 January 2014 diff hist 0 N File:Stribild description2.jpg No edit summary current
- 05:3705:37, 10 January 2014 diff hist 0 N File:Stribild description.jpg No edit summary current
- 05:3505:35, 10 January 2014 diff hist +1,158 N Elvitegravir cobicistat emtricitabine tenofovir warnings and precautions Created page with "__NOTOC__ {{Elvitegravir cobicistat emtricitabine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Warnings and Precautions== {| style="margin: 0 0 3em 3em; border: 3px solid #696969; wid..."
- 05:2505:25, 10 January 2014 diff hist +2,432 N Template:Elvitegravir cobicistat emtricitabine tenofovir Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8..." current
- 05:2305:23, 10 January 2014 diff hist +1,353 Elvitegravir cobicistat emtricitabine tenofovir No edit summary
- 05:2105:21, 10 January 2014 diff hist −82 Emtricitabine rilpivirine tenofovir →FDA Package Insert current
- 05:2105:21, 10 January 2014 diff hist −151 Template:Emtricitabine rilpivirine tenofovir No edit summary current
- 05:2005:20, 10 January 2014 diff hist +217 N Emtricitabine rilpivirine tenofovir labels and packages Created page with "__NOTOC__ {{Emtricitabine rilpivirine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Labels and Packages== 750px ==References== {{Reflist}} {{FDA}} Cat..." current
- 05:1905:19, 10 January 2014 diff hist 0 N File:Complera label.jpg No edit summary current
- 05:1805:18, 10 January 2014 diff hist 0 Emtricitabine rilpivirine tenofovir warnings and precautions No edit summary current
- 05:1705:17, 10 January 2014 diff hist +859 Emtricitabine rilpivirine tenofovir warnings and precautions No edit summary
- 05:1505:15, 10 January 2014 diff hist +1,055 N Emtricitabine rilpivirine tenofovir how supplied Created page with "__NOTOC__ {{Emtricitabine rilpivirine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==How Supplied== COMPLERA tablets are purplish-pink, capsule-shaped, film-coated, debossed with "GSI"..." current
- 05:1405:14, 10 January 2014 diff hist +909 N Emtricitabine rilpivirine tenofovir dosage and administration Created page with "__NOTOC__ {{Emtricitabine rilpivirine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Dosage and Administration== Adults: The recommended dose of COMPLERA is one tablet taken orally onc..." current
- 05:1205:12, 10 January 2014 diff hist +437 Emtricitabine rilpivirine tenofovir drug interactions No edit summary current
- 05:1205:12, 10 January 2014 diff hist +4,435 N Emtricitabine rilpivirine tenofovir drug interactions Created page with "__NOTOC__ {{Emtricitabine rilpivirine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Drug Interactions== COMPLERA is a complete regimen for the treatment of HIV-1 infection; therefore,..."
- 05:1105:11, 10 January 2014 diff hist 0 N File:Complera table 4.jpg No edit summary current
- 05:0705:07, 10 January 2014 diff hist +153 Template:Emtricitabine rilpivirine tenofovir No edit summary
- 05:0505:05, 10 January 2014 diff hist +2,422 N Emtricitabine rilpivirine tenofovir overdosage Created page with "__NOTOC__ {{Emtricitabine rilpivirine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Overdosage== If overdose occurs the patient must be monitored for evidence of toxicity. Treatment o..." current
- 05:0305:03, 10 January 2014 diff hist +73 Emtricitabine rilpivirine tenofovir adverse reactions No edit summary current
- 05:0305:03, 10 January 2014 diff hist +1,061 N Emtricitabine rilpivirine tenofovir adverse reactions Created page with "==Adverse Reactions== ADVERSE REACTIONS The following adverse drug reactions are discussed in other sections of the labeling: * Lactic Acidosis/Severe Hepatomegaly with Stea..."
- 05:0105:01, 10 January 2014 diff hist −46 Emtricitabine rilpivirine tenofovir warnings and precautions No edit summary
- 05:0005:00, 10 January 2014 diff hist +10,169 N Emtricitabine rilpivirine tenofovir warnings and precautions Created page with "__NOTOC__ {{Emtricitabine rilpivirine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Warnings and Precautions== '''Lactic Acidosis/Severe Hepatomegaly with Steatosis''' Lactic acidos..."
- 04:5504:55, 10 January 2014 diff hist +1,313 N Emtricitabine rilpivirine tenofovir contraindications Created page with "__NOTOC__ {{Emtricitabine rilpivirine tenofovir}} {{CMG}}; {{AE}} {{MM}} ==Contraindications== COMPLERA should not be coadministered with the following drugs, as significant ..." current
- 04:5304:53, 10 January 2014 diff hist +25 Emtricitabine rilpivirine tenofovir indications and usage No edit summary current